{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:11:18Z","timestamp":1793722278335,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Drug-induced mitochondrial toxicity is thought to be a common mechanism of drug hepatotoxicity. Xian-Ling-Gu-Bao (XLGB) oral preparation is a commonly used drug for osteoporosis in China. Classical safety evaluation studies have shown that the entire preparation and six Chinese herbal medicines have high safety, but the incidence of drug-induced liver damage due to XLGB remains high, the mechanism and toxic substances causing liver injury are still unclear. The purpose of this study is to identify compounds with potential mitochondrial liabilities in XLGB, and to clarify their underlying mechanisms and related pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The mitochondrial function analysis was performed using an extracellular flux assay, which simultaneously monitored both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). Through network pharmacology and in vitro experimental verification, the potential protein targets, signaling pathways and molecular mechanism of mitochondrial toxicity have been studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We observed a significant decrease in mitochondrial respiration of Psoraleae Fructus and its five compounds in fundamental bioenergetics parameters such as basal respiration, ATP-linked production and maximal respiration, indicating mitochondrial dysfunction. The network pharmacology results showed that the influence of XLGB on mitochondrial dysfunction was closely related to PI3K-Akt signaling pathway, mTOR signaling pathway and Apoptosis. Western blot showed that the levels of mTOR, p-mTOR (Ser2448), Raptor, PI3K (p110\u03b1), Beclin 1, ATG5 and Caspase-9 were up-regulated after treatment with psoralidin, psoralen and bavachin, and the expression of Bcl-2 was down-regulated after bavachinin treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The hepatotoxicity of XLGB is associated with mitochondrial dysfunction. Five compounds in Psoraleae Fructus showed mitochondrial damage, they are psoralidin, isobavachalcone, bavachinin, bavachin and psoralen, especially psoralidin showed significant reduction in reserve capacity and respiratory control ratios. The molecular mechanism is related to the activation of PI3K\/mTOR signaling pathway to inhibit autophagy and induce mitochondrial apoptosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03798-5","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:23:45Z","timestamp":1669919025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mitochondrial toxicants in Xian-Ling-Gu-Bao induce liver injury by regulating the PI3K\/mTOR signaling pathway: an in vitro study"],"prefix":"10.1186","volume":"22","author":[{"given":"Shujuan","family":"Piao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"3798_CR1","doi-asserted-by":"publisher","unstructured":"Senior JR. Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug Saf. 2014;37(Suppl 1):S9\u201317. https:\/\/doi.org\/10.1007\/s40264-014-0182-7.","DOI":"10.1007\/s40264-014-0182-7"},{"issue":"4","key":"3798_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","volume":"34","author":"D Han","year":"2013","unstructured":"Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ, et al. Regulation of drug-induced liver injury by signal transduction pathway: critical role of mitochondria. Trends Pharmacol Sci. 2013;34(4):243\u201353. https:\/\/doi.org\/10.1016\/j.tips.2013.01.009.","journal-title":"Trends Pharmacol Sci"},{"issue":"17\u201318","key":"3798_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","volume":"12","author":"JA Dykens","year":"2007","unstructured":"Dykens JA, Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov Today. 2007;12(17\u201318):777\u201385. https:\/\/doi.org\/10.1016\/j.drudis.2007.07.013.","journal-title":"Drug Discov Today"},{"key":"3798_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.taap.2006.12.013","volume":"220","author":"UA Boelsterli","year":"2007","unstructured":"Boelsterli UA, Lim PLK. Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol. 2007;220:92\u2013107. https:\/\/doi.org\/10.1016\/j.taap.2006.12.013.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3798_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","volume":"105","author":"JJ Xu","year":"2008","unstructured":"Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci. 2008;105(1):97\u2013105. https:\/\/doi.org\/10.1093\/toxsci\/kfn109.","journal-title":"Toxicol Sci"},{"key":"3798_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cld.2013.07.006","volume":"17","author":"VJ Navarro","year":"2013","unstructured":"Navarro VJ, Seeff LB. Liver injury induced by herbal complementary and alternative medicine. Clin Liver Dis. 2013;17:715\u201335. https:\/\/doi.org\/10.1016\/j.cld.2013.07.006.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"3798_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.14218\/JCTH.2020.00008","volume":"8","author":"M Pasalar","year":"2020","unstructured":"Pasalar M, Daneshfard B, Lankarani KB. Complementary and alternative medicine-related drug-induced liver injury in Iran. J Clin Transl Hepatol. 2020;8(1):106\u20137. https:\/\/doi.org\/10.14218\/JCTH.2020.00008.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"3798_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/imr.2021.0006","volume":"1","author":"AM Jaladat","year":"2022","unstructured":"Jaladat AM, Zareifar S, Daneshfard B, Shahriarirad R. Management of drug-induced liver injury with Persian medicine: case report. Integr Med Rep. 2022;1(1):3\u20136. https:\/\/doi.org\/10.1089\/imr.2021.0006.","journal-title":"Integr Med Rep"},{"key":"3798_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jep.2019.01.006","volume":"233","author":"JH Byeon","year":"2019","unstructured":"Byeon JH, Kil JH, Ahn YC, Son CG. Systematic review of published data on herb induced liver injury. J Ethnopharmacol. 2019;233:190\u20136. https:\/\/doi.org\/10.1016\/j.jep.2019.01.006.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3798_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12701\/yujm.2019.00297","volume":"37","author":"JI Suh","year":"2020","unstructured":"Suh JI. Drug-induced liver injury. Yeungnam Univ J Med. 2020;37(1):2\u201312 https:\/\/doi.org\/10.12701\/yujm.2019.00297.","journal-title":"Yeungnam Univ J Med"},{"key":"3798_CR11","doi-asserted-by":"publisher","first-page":"CD005467","DOI":"10.1002\/14651858.CD005467.pub2","volume":"3","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu JP, Xia Y. Chinese herbal medicines for treating osteoporosis. Coch Database Syst Rev. 2014;3:CD005467. https:\/\/doi.org\/10.1002\/14651858.CD005467.pub2.","journal-title":"Coch Database Syst Rev"},{"key":"3798_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fphar.2017.00273","volume":"8","author":"H Wu","year":"2017","unstructured":"Wu H, Zhong Q, Wang J, Wang M, Fang F, Xia Z, et al. Beneficial effects and toxicity studies of Xian-ling-gu-bao on bone metabolism in ovariectomized rats. Front Pharmacol. 2017;8:273. https:\/\/doi.org\/10.3389\/fphar.2017.00273.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3798_CR13","doi-asserted-by":"publisher","first-page":"e0118184","DOI":"10.1371\/journal.pone.0118184","volume":"10","author":"X Wang","year":"2015","unstructured":"Wang X, He Y, Guo B, Tsang MC, Tu F, Dai Y, et al. In vivo screening for anti-osteoporotic fraction from extract of herbal formula xianlinggubao in ovariectomized mice. PLoS One. 2015;10(2):e0118184. https:\/\/doi.org\/10.1371\/journal.pone.0118184.","journal-title":"PLoS One"},{"key":"3798_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jot.2017.11.001","volume":"12","author":"ZR Li","year":"2018","unstructured":"Li ZR, Cheng LM, Wang KZ, Yang NP, Yang SH, He W, et al. Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-a first multicentre, randomised, double-blind, placebo-controlled clinical trial. J Orthop Translat. 2018;12:36\u201344. https:\/\/doi.org\/10.1016\/j.jot.2017.11.001.","journal-title":"J Orthop Translat"},{"key":"3798_CR15","doi-asserted-by":"publisher","first-page":"1827528","DOI":"10.1155\/2018\/1827528","volume":"2018","author":"F Wang","year":"2018","unstructured":"Wang F, Shi L, Zhang Y, Wang K, Pei F, Zhu H, et al. A traditional herbal formula xianlinggubao for pain control and function improvement in patients with knee and hand osteoarthritis: a multicenter, randomized, open-label, controlled trial. Evid Based Complement Alternat Med. 2018;2018:1827528. https:\/\/doi.org\/10.1155\/2018\/1827528.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3798_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jep.2012.09.055","volume":"145","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Liu Y, Wang H, Li J, Ren J, Zhu L, et al. A 26-week repeated dose toxicity study of Xian-ling-gu-bao in Sprague-Dawley rats. J Ethnopharmacol. 2013;145:85\u201393. https:\/\/doi.org\/10.1016\/j.jep.2012.09.055.","journal-title":"J Ethnopharmacol"},{"key":"3798_CR17","doi-asserted-by":"publisher","first-page":"111910","DOI":"10.1016\/j.jep.2019.111910","volume":"239","author":"W Wu","year":"2019","unstructured":"Wu W, Wang T, Sun B, Liu D, Lin Z, Miao Y, et al. Xian-Ling-Gu-Bao induced inflammatory stress rat liver injury: inflammatory and oxidative stress playing important roles. J Ethnopharmacol. 2019;239:111910. https:\/\/doi.org\/10.1016\/j.jep.2019.111910.","journal-title":"J Ethnopharmacol"},{"issue":"5\u20136","key":"3798_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.drudis.2007.12.008","volume":"13","author":"DA Ferrick","year":"2008","unstructured":"Ferrick DA, Neilson A, Beeson C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov Today. 2008;13(5\u20136):268\u201374. https:\/\/doi.org\/10.1016\/j.drudis.2007.12.008.","journal-title":"Drug Discov Today"},{"key":"3798_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12906-020-03007-1","volume":"20","author":"H Bao","year":"2020","unstructured":"Bao H, Guo H, Feng Z, Li X. Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology. BMC Complement Med Ther. 2020;20:208. https:\/\/doi.org\/10.1186\/s12906-020-03007-1.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"3798_CR20","doi-asserted-by":"publisher","first-page":"100245","DOI":"10.1016\/j.xpro.2020.100245","volume":"2","author":"X Gu","year":"2020","unstructured":"Gu X, Ma Y, Liu Y, Wan Q. Measurement of mitochondrial respiration in adherent cells by seahorse XF96 cell Mito stress test. STAR Protoc. 2020;2(1):100245. https:\/\/doi.org\/10.1016\/j.xpro.2020.100245.","journal-title":"STAR Protoc"},{"issue":"12","key":"3798_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1515\/hsz-2012-0198","volume":"393","author":"BG Hill","year":"2012","unstructured":"Hill BG, Benavides GA, Lancaster Jr JR, Ballinger S, Dell\u2019Italia L, Zhang J, et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem. 2012;393(12):1485\u2013512. https:\/\/doi.org\/10.1515\/hsz-2012-0198.","journal-title":"Biol Chem"},{"key":"3798_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20110162","volume":"435","author":"MD Brand","year":"2011","unstructured":"Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011;435:297\u2013312. https:\/\/doi.org\/10.1042\/BJ20110162.","journal-title":"Biochem J"},{"key":"3798_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.freeradbiomed.2010.01.015","volume":"48","author":"BP Dranka","year":"2010","unstructured":"Dranka BP, Hill BG, Darley-Usmar VM. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic Biol Med. 2010;48:905\u201314. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.01.015.","journal-title":"Free Radic Biol Med"},{"key":"3798_CR24","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/ijms13021933","volume":"13","author":"R Domenis","year":"2012","unstructured":"Domenis R, Bisetto E, Rossi D, Comelli M, Mavelli I. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor factor 1. Int J Mol Sci. 2012;13:1933\u201350. https:\/\/doi.org\/10.3390\/ijms13021933.","journal-title":"Int J Mol Sci"},{"key":"3798_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tiv.2018.07.012","volume":"52","author":"K Tilmant","year":"2018","unstructured":"Tilmant K, Gerets H, De Ron P, Hanon E, Bento-Pereira C, Atienzar FA. In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development. Toxicol in Vitro. 2018;52:374\u201383. https:\/\/doi.org\/10.1016\/j.tiv.2018.07.012.","journal-title":"Toxicol in Vitro"},{"issue":"1","key":"3798_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/03602532.2011.604086","volume":"44","author":"D Pessayre","year":"2012","unstructured":"Pessayre D, Fromenty B, Berson A, Robin MA, Lett\u00e9ron P, Moreau R, et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev. 2012;44(1):34\u201387. https:\/\/doi.org\/10.3109\/03602532.2011.604086.","journal-title":"Drug Metab Rev"},{"key":"3798_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.pharmtox.40.1.353","volume":"40","author":"KB Wallace","year":"2000","unstructured":"Wallace KB, Starkov AA. Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol. 2000;40:353\u201388. https:\/\/doi.org\/10.1146\/annurev.pharmtox.40.1.353.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3798_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tiv.2015.02.011","volume":"29","author":"L Kamalian","year":"2015","unstructured":"Kamalian L, Chadwick AE, Bayliss M, French NS, Monshouwer M, Snoeys J, et al. The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death. Toxicol in Vitro. 2015;29:732\u201340. https:\/\/doi.org\/10.1016\/j.tiv.2015.02.011.","journal-title":"Toxicol in Vitro"},{"key":"3798_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tiv.2018.08.001","volume":"53","author":"L Kamalian","year":"2018","unstructured":"Kamalian L, Douglas O, Jolly CE, Snoeys J, Simic D, Monshouwer M, et al. The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity. Toxicol in Vitro. 2018;53:136\u201347. https:\/\/doi.org\/10.1016\/j.tiv.2018.08.001.","journal-title":"Toxicol in Vitro"},{"key":"3798_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.redox.2013.12.028","volume":"2","author":"W Dott","year":"2014","unstructured":"Dott W, Mistry P, Wright J, Cain K, Herbert KE. Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Redox Biol. 2014;2:224\u201333. https:\/\/doi.org\/10.1016\/j.redox.2013.12.028.","journal-title":"Redox Biol"},{"issue":"11","key":"3798_CR31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1080\/15384101.2015.1038685","volume":"14","author":"K Wang","year":"2015","unstructured":"Wang K. Autophagy and apoptosis in liver injury. Cell Cycle. 2015;14(11):1631\u201342. https:\/\/doi.org\/10.1080\/15384101.2015.1038685.","journal-title":"Cell Cycle"},{"key":"3798_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-020-2724-5","volume":"11","author":"M Noguchi","year":"2020","unstructured":"Noguchi M, Hirata N, Tanaka T, Suizu F, Nakajima H, Chiorini JA. Autophagy as a modulator of cell death machinery. Cell Death Dis. 2020;11:517. https:\/\/doi.org\/10.1038\/s41419-020-2724-5.","journal-title":"Cell Death Dis"},{"key":"3798_CR33","doi-asserted-by":"publisher","first-page":"4701275","DOI":"10.1155\/2018\/4701275","volume":"2018","author":"KF Cooper","year":"2018","unstructured":"Cooper KF. Till death do us part: the marriage of autophagy and apoptosis. Oxidative Med Cell Longev. 2018;2018:4701275. https:\/\/doi.org\/10.1155\/2018\/4701275.","journal-title":"Oxidative Med Cell Longev"},{"key":"3798_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890.2015.1040831","volume":"47","author":"GX Zhao","year":"2015","unstructured":"Zhao GX, Pan H, Ouyang DY, He XH. The critical molecular interconnections in regulating apoptosis and autophagy. Ann Med. 2015;47:305\u201315. https:\/\/doi.org\/10.3109\/07853890.2015.1040831.","journal-title":"Ann Med"},{"issue":"6046","key":"3798_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333(6046):1109\u201312. https:\/\/doi.org\/10.1126\/science.1201940.","journal-title":"Science"},{"key":"3798_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/emboj.2009.377","volume":"29","author":"MC Maiuri","year":"2010","unstructured":"Maiuri MC, Criollo A, Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J. 2010;29:515\u20136. https:\/\/doi.org\/10.1038\/emboj.2009.377.","journal-title":"EMBO J"},{"key":"3798_CR37","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/cddis.2009.16","volume":"1","author":"E Wirawan","year":"2010","unstructured":"Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, et al. Caspase-mediated cleavage of Beclin 1 inactivates Beclin 1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010;1:e18. https:\/\/doi.org\/10.1038\/cddis.2009.16.","journal-title":"Cell Death Dis"},{"issue":"21","key":"3798_CR38","doi-asserted-by":"publisher","first-page":"20722","DOI":"10.1074\/jbc.M413934200","volume":"280","author":"JO Pyo","year":"2005","unstructured":"Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, Woo HN, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem. 2005;280(21):20722\u20139. https:\/\/doi.org\/10.1074\/jbc.M413934200.","journal-title":"J Biol Chem"},{"issue":"10","key":"3798_CR39","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ncb1482","volume":"8","author":"S Yousefi","year":"2006","unstructured":"Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, et al. Calpain-mediated cleavage of Atg5 switchs autophagy to apoptosis. Nat Cell Biol. 2006;8(10):1124\u201332. https:\/\/doi.org\/10.1038\/ncb1482.","journal-title":"Nat Cell Biol"},{"key":"3798_CR40","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/cdd.2009.33","volume":"16","author":"A Eisenberg-Lerner","year":"2009","unstructured":"Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16:966\u201375. https:\/\/doi.org\/10.1038\/cdd.2009.33.","journal-title":"Cell Death Differ"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03798-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:24:04Z","timestamp":1669919044000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03798-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3798"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03798-5","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}